Latest news
DXB: Advancing kidney disease therapies with global deals and a diversified, risk-managed approach - TradingViewTradingView · Thu, 06 Aug 2026 22:21:44 GMTDXB:ASX Announcement - Dimerix Presents at Bioshares Summit 2026 - 06 Aug 2026 - Market IndexMarket Index · Thu, 06 Aug 2026 04:10:01 GMTDimerix Limited (SBMJF) Presents at 2026 Bioshares Biotech Summit - New Zealand - Slideshow - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 03:04:21 GMTDimerix (ASX:DXB) Builds Pipeline Momentum With Phase 3 Progress and New Commercial Partnership - kalkine.com.aukalkine.com.au · Thu, 30 Jul 2026 01:53:00 GMTDimerix acquisition of DMX-652 bolsters kidney disease development - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTDimerix (ASX:DXB) Expands Kidney Pipeline With DMX-652 Acquisition and Long-Dated Patent Protection - kalkine.com.aukalkine.com.au · Tue, 28 Jul 2026 13:13:00 GMTLong Shortz with Dimerix - The AustralianThe Australian · Mon, 27 Jul 2026 07:00:00 GMTDimerix to Present Phase 3 FSGS Trial Update and Acute Kidney Injury Program at TechKnow Invest Conference - kalkine.com.aukalkine.com.au · Mon, 27 Jul 2026 07:00:00 GMT